English
简体中文
Total: £ 56.28
Published Date: 2024-12-04 | Pages: 98 | Tables: 207 | Pharma & Healthcare
The global market for Isoxazoline Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Isoxazoline Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Isoxazoline Drugs by region & country, by Type, and by Application.
The Isoxazoline Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Isoxazoline Drugs.
Market Segmentation
By Company
Merck Animal Health Inc.
Elanco Animal Health Incorporated
Boehringer Ingelheim International GmbH
Zoetis Inc
Nissan Chemical Corporation
Segment by Type:
Fluralaner
Afoxolaner
Sarolaner
Lotilaner
Others
Segment by Application
Dog
Cat
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Isoxazoline Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Isoxazoline Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Isoxazoline Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Isoxazoline Drugs Product Introduction
1.2 Global Isoxazoline Drugs Market Size Forecast
1.2.1 Global Isoxazoline Drugs Sales Value (2019-2030)
1.2.2 Global Isoxazoline Drugs Sales Volume (2019-2030)
1.2.3 Global Isoxazoline Drugs Sales Price (2019-2030)
1.3 Isoxazoline Drugs Market Trends & Drivers
1.3.1 Isoxazoline Drugs Industry Trends
1.3.2 Isoxazoline Drugs Market Drivers & Opportunity
1.3.3 Isoxazoline Drugs Market Challenges
1.3.4 Isoxazoline Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Isoxazoline Drugs Players Revenue Ranking (2023)
2.2 Global Isoxazoline Drugs Revenue by Company (2019-2024)
2.3 Global Isoxazoline Drugs Players Sales Volume Ranking (2023)
2.4 Global Isoxazoline Drugs Sales Volume by Company Players (2019-2024)
2.5 Global Isoxazoline Drugs Average Price by Company (2019-2024)
2.6 Key Manufacturers Isoxazoline Drugs Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Isoxazoline Drugs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Isoxazoline Drugs
2.9 Isoxazoline Drugs Market Competitive Analysis
2.9.1 Isoxazoline Drugs Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Isoxazoline Drugs Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isoxazoline Drugs as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Fluralaner
3.1.2 Afoxolaner
3.1.3 Sarolaner
3.1.4 Lotilaner
3.1.5 Others
3.2 Global Isoxazoline Drugs Sales Value by Type
3.2.1 Global Isoxazoline Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Isoxazoline Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Isoxazoline Drugs Sales Value, by Type (%) (2019-2030)
3.3 Global Isoxazoline Drugs Sales Volume by Type
3.3.1 Global Isoxazoline Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Isoxazoline Drugs Sales Volume, by Type (2019-2030)
3.3.3 Global Isoxazoline Drugs Sales Volume, by Type (%) (2019-2030)
3.4 Global Isoxazoline Drugs Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Dog
4.1.2 Cat
4.1.3 Others
4.2 Global Isoxazoline Drugs Sales Value by Application
4.2.1 Global Isoxazoline Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Isoxazoline Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Isoxazoline Drugs Sales Value, by Application (%) (2019-2030)
4.3 Global Isoxazoline Drugs Sales Volume by Application
4.3.1 Global Isoxazoline Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Isoxazoline Drugs Sales Volume, by Application (2019-2030)
4.3.3 Global Isoxazoline Drugs Sales Volume, by Application (%) (2019-2030)
4.4 Global Isoxazoline Drugs Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Isoxazoline Drugs Sales Value by Region
5.1.1 Global Isoxazoline Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Isoxazoline Drugs Sales Value by Region (2019-2024)
5.1.3 Global Isoxazoline Drugs Sales Value by Region (2025-2030)
5.1.4 Global Isoxazoline Drugs Sales Value by Region (%), (2019-2030)
5.2 Global Isoxazoline Drugs Sales Volume by Region
5.2.1 Global Isoxazoline Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Isoxazoline Drugs Sales Volume by Region (2019-2024)
5.2.3 Global Isoxazoline Drugs Sales Volume by Region (2025-2030)
5.2.4 Global Isoxazoline Drugs Sales Volume by Region (%), (2019-2030)
5.3 Global Isoxazoline Drugs Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Isoxazoline Drugs Sales Value, 2019-2030
5.4.2 North America Isoxazoline Drugs Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Isoxazoline Drugs Sales Value, 2019-2030
5.5.2 Europe Isoxazoline Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Isoxazoline Drugs Sales Value, 2019-2030
5.6.2 Asia Pacific Isoxazoline Drugs Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Isoxazoline Drugs Sales Value, 2019-2030
5.7.2 South America Isoxazoline Drugs Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Isoxazoline Drugs Sales Value, 2019-2030
5.8.2 Middle East & Africa Isoxazoline Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Isoxazoline Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Isoxazoline Drugs Sales Value
6.2.1 Key Countries/Regions Isoxazoline Drugs Sales Value, 2019-2030
6.2.2 Key Countries/Regions Isoxazoline Drugs Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Isoxazoline Drugs Sales Value, 2019-2030
6.3.2 United States Isoxazoline Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Isoxazoline Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Isoxazoline Drugs Sales Value, 2019-2030
6.4.2 Europe Isoxazoline Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Isoxazoline Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Isoxazoline Drugs Sales Value, 2019-2030
6.5.2 China Isoxazoline Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Isoxazoline Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Isoxazoline Drugs Sales Value, 2019-2030
6.6.2 Japan Isoxazoline Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Isoxazoline Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Isoxazoline Drugs Sales Value, 2019-2030
6.7.2 South Korea Isoxazoline Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Isoxazoline Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Isoxazoline Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Isoxazoline Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Isoxazoline Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Isoxazoline Drugs Sales Value, 2019-2030
6.9.2 India Isoxazoline Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Isoxazoline Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck Animal Health Inc.
7.1.1 Merck Animal Health Inc. Company Information
7.1.2 Merck Animal Health Inc. Introduction and Business Overview
7.1.3 Merck Animal Health Inc. Isoxazoline Drugs Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Merck Animal Health Inc. Isoxazoline Drugs Product Offerings
7.1.5 Merck Animal Health Inc. Recent Development
7.2 Elanco Animal Health Incorporated
7.2.1 Elanco Animal Health Incorporated Company Information
7.2.2 Elanco Animal Health Incorporated Introduction and Business Overview
7.2.3 Elanco Animal Health Incorporated Isoxazoline Drugs Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Elanco Animal Health Incorporated Isoxazoline Drugs Product Offerings
7.2.5 Elanco Animal Health Incorporated Recent Development
7.3 Boehringer Ingelheim International GmbH
7.3.1 Boehringer Ingelheim International GmbH Company Information
7.3.2 Boehringer Ingelheim International GmbH Introduction and Business Overview
7.3.3 Boehringer Ingelheim International GmbH Isoxazoline Drugs Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Boehringer Ingelheim International GmbH Isoxazoline Drugs Product Offerings
7.3.5 Boehringer Ingelheim International GmbH Recent Development
7.4 Zoetis Inc
7.4.1 Zoetis Inc Company Information
7.4.2 Zoetis Inc Introduction and Business Overview
7.4.3 Zoetis Inc Isoxazoline Drugs Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Zoetis Inc Isoxazoline Drugs Product Offerings
7.4.5 Zoetis Inc Recent Development
7.5 Nissan Chemical Corporation
7.5.1 Nissan Chemical Corporation Company Information
7.5.2 Nissan Chemical Corporation Introduction and Business Overview
7.5.3 Nissan Chemical Corporation Isoxazoline Drugs Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Nissan Chemical Corporation Isoxazoline Drugs Product Offerings
7.5.5 Nissan Chemical Corporation Recent Development
8 Industry Chain Analysis
8.1 Isoxazoline Drugs Industrial Chain
8.2 Isoxazoline Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Isoxazoline Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Isoxazoline Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Isoxazoline Drugs Market Trends
Table 2. Isoxazoline Drugs Market Drivers & Opportunity
Table 3. Isoxazoline Drugs Market Challenges
Table 4. Isoxazoline Drugs Market Restraints
Table 5. Global Isoxazoline Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Isoxazoline Drugs Revenue Market Share by Company (2019-2024)
Table 7. Global Isoxazoline Drugs Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Isoxazoline Drugs Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Isoxazoline Drugs Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Isoxazoline Drugs Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Isoxazoline Drugs Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Isoxazoline Drugs
Table 13. Global Isoxazoline Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isoxazoline Drugs as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Isoxazoline Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Isoxazoline Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Isoxazoline Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Isoxazoline Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Isoxazoline Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Isoxazoline Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Isoxazoline Drugs Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Isoxazoline Drugs Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Isoxazoline Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Isoxazoline Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Isoxazoline Drugs Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Isoxazoline Drugs Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Isoxazoline Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Isoxazoline Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Isoxazoline Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Isoxazoline Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Isoxazoline Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Isoxazoline Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Isoxazoline Drugs Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Isoxazoline Drugs Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Isoxazoline Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Isoxazoline Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Isoxazoline Drugs Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Isoxazoline Drugs Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Isoxazoline Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Isoxazoline Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Isoxazoline Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Isoxazoline Drugs Sales Value by Region (2019-2024) & (%)
Table 44. Global Isoxazoline Drugs Sales Value by Region (2025-2030) & (%)
Table 45. Global Isoxazoline Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Isoxazoline Drugs Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Isoxazoline Drugs Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Isoxazoline Drugs Sales Volume by Region (2019-2024) & (%)
Table 49. Global Isoxazoline Drugs Sales Volume by Region (2025-2030) & (%)
Table 50. Global Isoxazoline Drugs Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Isoxazoline Drugs Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Isoxazoline Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Isoxazoline Drugs Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Isoxazoline Drugs Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Isoxazoline Drugs Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Isoxazoline Drugs Sales Volume, (2025-2030) & (K Units)
Table 57. Merck Animal Health Inc. Company Information
Table 58. Merck Animal Health Inc. Introduction and Business Overview
Table 59. Merck Animal Health Inc. Isoxazoline Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Merck Animal Health Inc. Isoxazoline Drugs Product Offerings
Table 61. Merck Animal Health Inc. Recent Development
Table 62. Elanco Animal Health Incorporated Company Information
Table 63. Elanco Animal Health Incorporated Introduction and Business Overview
Table 64. Elanco Animal Health Incorporated Isoxazoline Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Elanco Animal Health Incorporated Isoxazoline Drugs Product Offerings
Table 66. Elanco Animal Health Incorporated Recent Development
Table 67. Boehringer Ingelheim International GmbH Company Information
Table 68. Boehringer Ingelheim International GmbH Introduction and Business Overview
Table 69. Boehringer Ingelheim International GmbH Isoxazoline Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Boehringer Ingelheim International GmbH Isoxazoline Drugs Product Offerings
Table 71. Boehringer Ingelheim International GmbH Recent Development
Table 72. Zoetis Inc Company Information
Table 73. Zoetis Inc Introduction and Business Overview
Table 74. Zoetis Inc Isoxazoline Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Zoetis Inc Isoxazoline Drugs Product Offerings
Table 76. Zoetis Inc Recent Development
Table 77. Nissan Chemical Corporation Company Information
Table 78. Nissan Chemical Corporation Introduction and Business Overview
Table 79. Nissan Chemical Corporation Isoxazoline Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Nissan Chemical Corporation Isoxazoline Drugs Product Offerings
Table 81. Nissan Chemical Corporation Recent Development
Table 82. Key Raw Materials Lists
Table 83. Raw Materials Key Suppliers Lists
Table 84. Isoxazoline Drugs Downstream Customers
Table 85. Isoxazoline Drugs Distributors List
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Isoxazoline Drugs Product Picture
Figure 2. Global Isoxazoline Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Isoxazoline Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Isoxazoline Drugs Sales Volume (2019-2030) & (K Units)
Figure 5. Global Isoxazoline Drugs Sales Price (2019-2030) & (US$/Unit)
Figure 6. Isoxazoline Drugs Report Years Considered
Figure 7. Global Isoxazoline Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Isoxazoline Drugs Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Isoxazoline Drugs Revenue in 2023
Figure 10. Isoxazoline Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Fluralaner Picture
Figure 12. Afoxolaner Picture
Figure 13. Sarolaner Picture
Figure 14. Lotilaner Picture
Figure 15. Others Picture
Figure 16. Global Isoxazoline Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Isoxazoline Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 18. Global Isoxazoline Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 19. Global Isoxazoline Drugs Sales Volume Market Share by Type, 2023 & 2030
Figure 20. Global Isoxazoline Drugs Price by Type (2019-2030) & (US$/Unit)
Figure 21. Product Picture of Dog
Figure 22. Product Picture of Cat
Figure 23. Product Picture of Others
Figure 24. Global Isoxazoline Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 25. Global Isoxazoline Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 26. Global Isoxazoline Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 27. Global Isoxazoline Drugs Sales Volume Market Share by Application, 2023 & 2030
Figure 28. Global Isoxazoline Drugs Price by Application (2019-2030) & (US$/Unit)
Figure 29. North America Isoxazoline Drugs Sales Value (2019-2030) & (US$ Million)
Figure 30. North America Isoxazoline Drugs Sales Value by Country (%), 2023 VS 2030
Figure 31. Europe Isoxazoline Drugs Sales Value (2019-2030) & (US$ Million)
Figure 32. Europe Isoxazoline Drugs Sales Value by Country (%), 2023 VS 2030
Figure 33. Asia Pacific Isoxazoline Drugs Sales Value (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Isoxazoline Drugs Sales Value by Country (%), 2023 VS 2030
Figure 35. South America Isoxazoline Drugs Sales Value (2019-2030) & (US$ Million)
Figure 36. South America Isoxazoline Drugs Sales Value by Country (%), 2023 VS 2030
Figure 37. Middle East & Africa Isoxazoline Drugs Sales Value (2019-2030) & (US$ Million)
Figure 38. Middle East & Africa Isoxazoline Drugs Sales Value by Country (%), 2023 VS 2030
Figure 39. Key Countries/Regions Isoxazoline Drugs Sales Value (%), (2019-2030)
Figure 40. Key Countries/Regions Isoxazoline Drugs Sales Volume (%), (2019-2030)
Figure 41. United States Isoxazoline Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 42. United States Isoxazoline Drugs Sales Value by Type (%), 2023 VS 2030
Figure 43. United States Isoxazoline Drugs Sales Value by Application (%), 2023 VS 2030
Figure 44. Europe Isoxazoline Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 45. Europe Isoxazoline Drugs Sales Value by Type (%), 2023 VS 2030
Figure 46. Europe Isoxazoline Drugs Sales Value by Application (%), 2023 VS 2030
Figure 47. China Isoxazoline Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 48. China Isoxazoline Drugs Sales Value by Type (%), 2023 VS 2030
Figure 49. China Isoxazoline Drugs Sales Value by Application (%), 2023 VS 2030
Figure 50. Japan Isoxazoline Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 51. Japan Isoxazoline Drugs Sales Value by Type (%), 2023 VS 2030
Figure 52. Japan Isoxazoline Drugs Sales Value by Application (%), 2023 VS 2030
Figure 53. South Korea Isoxazoline Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 54. South Korea Isoxazoline Drugs Sales Value by Type (%), 2023 VS 2030
Figure 55. South Korea Isoxazoline Drugs Sales Value by Application (%), 2023 VS 2030
Figure 56. Southeast Asia Isoxazoline Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 57. Southeast Asia Isoxazoline Drugs Sales Value by Type (%), 2023 VS 2030
Figure 58. Southeast Asia Isoxazoline Drugs Sales Value by Application (%), 2023 VS 2030
Figure 59. India Isoxazoline Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 60. India Isoxazoline Drugs Sales Value by Type (%), 2023 VS 2030
Figure 61. India Isoxazoline Drugs Sales Value by Application (%), 2023 VS 2030
Figure 62. Isoxazoline Drugs Industrial Chain
Figure 63. Isoxazoline Drugs Manufacturing Cost Structure
Figure 64. Channels of Distribution (Direct Sales, and Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
